Gynecologic Cancer
Specialty Channel

Featured Article
Post-operative systemic chemo and RT did not improve OS in high-risk patients with stage I endometrial cancer, according to Rachelle Findley, MD, et al.
Findings from a study presented at the 2021 SGO Virtual Annual Meeting on Women's Cancer, frail patients with ovarian cancer who undergo surgery at institutions with higher surgical volume have lower…
In a session presented at the 2021 SGO Annual Meeting on Women’s Cancer Rebecca Kristeleit, PhD, UCL Cancer Institute, London, shared findings from the ARIEL4 study on rucaparib versus chemotherapy.
A Swedish study found that women who received the quadrivalent HPV vaccine were less likely to contract invasive cervical cancer than those who had not.
According to the ARIEL3 study, _______ extended PFS for ovarian cancer despite toxicities?
Evaluating women for postmenopausal bleeding aids in the early detection of, and implementation of prevention strategies for, endometrial cancer.
Focusing on patient-centered outcomes from the ARIEL3 trial, rucaparib extended PFS in the maintenance setting for ovarian cancer despite toxicities.
True or False: Pembrolizumab provided a durable clinical response in cisplatin-ineligible patients with advanced urothelial carcinoma and is associated with prolonged OS.
Tumor-specific TP53 variants were detected in Papanicolaou tests for routine cervical cancer screenings up to 6 years before ovarian cancer diagnosis.

News

Post-operative systemic chemo and RT did not improve OS in high-risk patients with stage I endometrial cancer, according to Rachelle Findley, MD, et al.
Findings from a study presented at the 2021 SGO Virtual Annual Meeting on Women's Cancer, frail patients with ovarian cancer who undergo surgery at institutions with higher surgical volume have lower…
In a session presented at the 2021 SGO Annual Meeting on Women’s Cancer Rebecca Kristeleit, PhD, UCL Cancer Institute, London, shared findings from the ARIEL4 study on rucaparib versus chemotherapy.
A Swedish study found that women who received the quadrivalent HPV vaccine were less likely to contract invasive cervical cancer than those who had not.

Interactive Features

According to the ARIEL3 study, _______ extended PFS for ovarian cancer despite toxicities?
True or False: Pembrolizumab provided a durable clinical response in cisplatin-ineligible patients with advanced urothelial carcinoma and is associated with prolonged OS.
True or false: Maintenance olaparib did not provide a significant OS improvement in a phase 3 study of patients with platinum-sensitive, BRCA-mutated, relapsed ovarian cancer.
True or false: Maintenance pazopanib improved overall survival in advanced ovarian cancer in a phase 3 clinical trial.
Stay in the know.
OncNet Newsletter